Latest News

  • Alkermes to Present Data on ALKS 5461 at Upcoming Society of Biological Psychiatry Annual Meeting Read More
  • Alkermes Announces Completion of Patient Enrollment in Pivotal Antipsychotic Efficacy Study of ALKS 3831 for Schizophrenia Read More
  • Alkermes plc Reports First Quarter 2017 Financial Results Read More

Investors

Learn more Learn More Alkermes PLC Investor Relations

Working at Alkermes

Join Our Team Join Our Team Working at Alkermes